Skip to main content

Table 2 Baseline patients characteristics, n (%) or mean ± standard deviation (SD) or median (25th–75th)

From: Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China

 HDPDKT (first year)KT (second year)
No. Patients3765123711741
Gender: Male2089(55.5)683(55.2)82(70.1)31(75.6)
Age (years)
 Mean ± SD57.5 ± 15.851.1 ± 16.137.0 ± 9.739.0 ± 11.2
Age Group
 18–45 years827(22.0)472(38.2)93(79.5)29(70.7)
 45–60 years1166(31.0)357(28.9)23(19.7)11(26.8)
 60–75 years1168(31.0)305(24.7)1(0.9)1(2.4)
  ≥ 75 years604(16.0)103(8.3)0(0.0)0(0.0)
Comorbidities
 None1520(40.4)703(56.8)77(65.8)28(68.3)
 Hypertension2042(54.2)468(37.8)38(32.5)12(29.3)
 Diabetes1057(28.1)271(21.9)7(6.0)4(9.8)
 Coronary362(9.6)52(4.2)2(1.7)0(0.0)
Insurance type
 UEBMI3341(88.7)1137(91.9)117(100.0)41(100.0)
 URBMI424(11.3)100(8.1)0(0.0)0(0.0)
  1. HD Haemodialysis, PD Peritoneal Dialysis, KT Kidney Transplantation, UEBMI Urban Employee-based Basic Medical Insurance scheme, URBMI Urban Resident-based Basic Medical Insurance scheme
\